What must a pharmacist document when receiving a DEA 222 form for controlled substances?

When a pharmacist receives a DEA 222 form for controlled substances, it is essential to document the number of containers received and the date of receipt. This requirement ensures proper tracking and accountability of controlled substances throughout the supply chain. The DEA 222 form is a critical document used in the ordering of Schedule I and II controlled substances, and accurate recordkeeping is vital to comply with federal regulations regarding the handling of these substances.

Recording the number of containers helps maintain an accurate inventory and prevents discrepancies that could lead to potential legal issues or concerns about misuse or diversion of controlled substances. Additionally, noting the specific date of receipt confirms when the substances were obtained, which is crucial for auditing and tracking purposes. These documentation practices align with pharmacy law and ensure that pharmacists uphold their responsibilities regarding controlled substances.